GI Cancer

BEACON trial in colorectal cancer slammed by haematologist-oncologist

A phase III study in metastatic colorectal cancer presented at ESMO and published simultaneously in the NEJM has been slammed by a haematologist-oncologist as the “single worst reported randomised trial” he has ever read. Vinay Prasad, an associate professor of medicine at Oregon Health and Science University in Portland, Oregon, criticised the BEACON study on ...

Already a member?

Login to keep reading.

© 2022 the limbic